BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fukuda R, Sugawara S, Kondo Y. Immune Checkpoint Inhibitor Can Reduce HCV-RNA without Liver Damage. Intern Med 2020;59:2245-8. [PMID: 32522918 DOI: 10.2169/internalmedicine.3726-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Peña-Asensio J, Calvo H, Torralba M, Miquel J, Sanz-de-Villalobos E, Larrubia JR. Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C. Cells 2021;10:538. [PMID: 33802622 DOI: 10.3390/cells10030538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kondo Y, Akahira J, Morosawa T, Toi Y, Endo A, Satio H, Endo M, Sugawara S, Tanaka Y. Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment. Sci Rep 2022;12:3669. [PMID: 35256688 DOI: 10.1038/s41598-022-07770-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang R, Lin N, Mao B, Wu Q. The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals. J Cancer Res Clin Oncol 2021. [PMID: 34297207 DOI: 10.1007/s00432-021-03716-1] [Reference Citation Analysis]
4 de Almeida NAA, Ribeiro CRA, Raposo JV, de Paula VS. Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review. Viruses 2021;13:822. [PMID: 34063186 DOI: 10.3390/v13050822] [Reference Citation Analysis]